Literature DB >> 8513395

The mitochondrial DNA transfer RNA(Lys)A-->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA.

S R Hammans1, M G Sweeney, M Brockington, G G Lennox, N F Lawton, C R Kennedy, J A Morgan-Hughes, A E Harding.   

Abstract

The mitochondrial DNA (mtDNA) transfer RNA (tRNA)Lys A-->G(8344) mutation was identified in seven patients. These patients and their relatives were assessed clinically; in one family the mutation was deduced to be present in four generations. The phenotype in index cases was consistent with the syndrome of myoclonic epilepsy with ragged red fibres, with the core clinical features of myoclonus, ataxia and seizures. Amongst other features, progressive external ophthalmoplegia, Leigh's syndrome and stroke-like episodes were observed, well recognized in mitochondrial myopathies but novel manifestations of this genotype. Samples of blood and muscle were analysed for the proportion of mutant mtDNA using an oligonucleotide hybridization technique. The proportion of mutant mtDNA in blood was significantly greater in symptomatic than asymptomatic cases. Furthermore, the proportion of mutant mtDNA in blood correlated with age of onset of disease and clinical severity assessed by a simple scale. Study of disease associated with the tRNA(Lys) A-->G(8344) mutation provides further insight into the pathogenesis and transmission of mitochondrial diseases. Quantification of the proportion of mtDNA in tissues demonstrates that this is a major factor determining the course of disease, but other, as yet unidentified factors are also likely to play a role.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513395     DOI: 10.1093/brain/116.3.617

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  37 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates.

Authors:  L Zhou; A Chomyn; G Attardi; C A Miller
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes.

Authors:  Ioannis Zaganas; Helen Latsoudis; Eufrosini Papadaki; Pelagia Vorgia; Martha Spilioti; Andreas Plaitakis
Journal:  J Neurol       Date:  2009-02-27       Impact factor: 4.849

4.  Clinical variability associated with the mutation at nucleotide position 8344 of the mitochondrial DNA.

Authors:  Y Campos; M A Martín; J Vaamonde; A Cabello; J Esteban; J Arenas
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 5.  Mitochondrial genetics '98 is the bottleneck cracked?

Authors:  J Poulton; V Macaulay; D R Marchington
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  Variable levels of a heteroplasmic point mutation in individual hair roots.

Authors:  K E Bendall; V A Macaulay; B C Sykes
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

Review 7.  The inherited ataxias and the new genetics.

Authors:  S R Hammans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

8.  Previous estimates of mitochondrial DNA mutation level variance did not account for sampling error: comparing the mtDNA genetic bottleneck in mice and humans.

Authors:  Passorn Wonnapinij; Patrick F Chinnery; David C Samuels
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

9.  Clinical features of adverse reactions associated with telbivudine.

Authors:  Xue-Song Zhang; Rui Jin; Shi-Bin Zhang; Ming-Ling Tao
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

10.  The G16319A substitution frequency in a hemorrhagic stroke.

Authors:  Barbara Gaweł; Joanna Głogowska-Ligus; Urszula Mazurek
Journal:  Ann Indian Acad Neurol       Date:  2008-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.